drugset / Trial / NCT01805115

Misoprostol Administration Before Operative Hysteroscopy

NCT01805115 ↗

Phase 3 Completed 120 enrolled CHA University
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to compare the efficacy of oral, sublingual, vaginal, and no misoprostol prior to operative hysteroscopy in premenopausal women.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-02

Outcome

Met primary endpoint

paper The mean (±SD) cervical widths for the oral, sublingual, vaginal, and control groups were 7.62±1.81 mm, 7.58±1.77 mm, 7.60±2.15 mm, and 5.65±2.12 mm, respectively, which was statistically significant. PMID 24856464 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Oral

Indications